tumor

Sperm, bacteria, bubbles, and shuttles are just some of the latest cancer-treating microrobots in development for human use in the next few years.

Immunotherapy was a game-changer for the cancer field, but immunotherapies using cytokines like IL-2 often cause severe side effects. Researchers are developing a newly engineered blueprint to improve the therapeutic efficacy and safety of IL-2 and other cytokines.

Grant from Innovate UK to Pathios seeks to advance cancer immunotherapy

Oncologists seek clarity via patient-derived models

Study teams up protein biomarkers to increase accuracy of early breast cancer detection